A meta-analysis of nearly 25,000 patients undergoing radical prostatectomy supports adding presurgery MRI findings to ...
Dr. Sandy Srinivas explains how age, comorbidities and medications influence personalized prostate cancer treatment decisions ...
From his perspective, one of the most persistent misconceptions in prostate cancer care relates to how patients interpret ...
Prostate Cancer Awareness Prostate-related health issues are becoming increasingly prevalent among older men, with prostate ...
A new randomized clinical trial found that men with localized, intermediate‑risk prostate cancer recovered faster and ...
More than 35,000 men in the United States die from prostate cancer each year. Now, a new study reveals the immune cell ...
Researchers have discovered that the immune system's T cells can travel to the prostate to provide long-term protection against infections. Their findings suggest we might harness these same ...
We’re in a room in the Emirates Arena in Glasgow just above the track where the cyclists are doing lap after lap (we are here because of ...
A 2026 informational report examining ProstaCleanse prostate cleanse ingredient disclosures, Dr. Shawn Marhamati ...
Top cancer specialists are urging men to look past the common symptoms of aging and recognize these critical warning signs. It’s often said that if you have your health, you have everything, and there ...
Pfizer is eyeing an earlier use of its PARP inhibitor Talzenna after a positive phase 3 trial in metastatic hormone-sensitive prostate cancer (mHSPC). The phase 3 Talapro-3 trial met its primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results